Share Price and Basic Stock Data
Last Updated: September 5, 2025, 5:12 pm
PEG Ratio | -1.20 |
---|
Quick Insight
Rupa & Company Ltd, within the textiles – hosiery/knitwear sector, presents a compelling investment opportunity with a current share price of 192 and a market capitalization of 1,530 Cr. The company's P/E ratio stands at 19.2, indicating a reasonable valuation, while the ROE and ROCE at 8.39% and 10.9% respectively reflect decent profitability and capital efficiency. With a low OPM of 6.65%, there is room for margin improvement. The healthy reserves of 1,010 Cr and manageable borrowings of ₹238 Cr provide financial stability, although a CCC of 340 days warrants attention. Overall, Rupa & Company's solid fundamentals and growth potential make it worth considering for investors seeking exposure to the textile industry.
Competitors of Rupa & Company Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Filatex Fashions Ltd | 467 Cr. | 0.57 | 1.35/0.42 | 55.0 | 2.77 | 0.00 % | 0.63 % | 0.41 % | 1.00 |
Alan Scott Industries Ltd | 125 Cr. | 230 | 239/85.2 | 3.28 | 0.00 % | 3.88 % | 64.7 % | 10.0 | |
Addi Industries Ltd | 113 Cr. | 105 | 132/36.4 | 27.6 | 73.4 | 1.20 % | 5.51 % | 4.15 % | 5.00 |
T T Ltd (TTL) | 278 Cr. | 10.9 | 19.5/10.4 | 3.49 | 0.46 % | 1.49 % | 8.57 % | 1.00 | |
Rupa & Company Ltd | 1,568 Cr. | 197 | 340/174 | 19.7 | 128 | 1.52 % | 10.9 % | 8.39 % | 1.00 |
Industry Average | 620.44 Cr | 116.04 | 39.36 | 84.30 | 0.49% | 5.47% | 10.73% | 4.60 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 214.67 | 285.62 | 236.00 | 406.79 | 195.44 | 302.09 | 318.51 | 400.48 | 210.29 | 297.10 | 316.44 | 415.48 | 183.90 |
Expenses | 196.19 | 256.37 | 221.87 | 379.44 | 184.10 | 269.65 | 285.57 | 360.09 | 192.29 | 268.59 | 278.41 | 369.61 | 171.67 |
Operating Profit | 18.48 | 29.25 | 14.13 | 27.35 | 11.34 | 32.44 | 32.94 | 40.39 | 18.00 | 28.51 | 38.03 | 45.87 | 12.23 |
OPM % | 8.61% | 10.24% | 5.99% | 6.72% | 5.80% | 10.74% | 10.34% | 10.09% | 8.56% | 9.60% | 12.02% | 11.04% | 6.65% |
Other Income | 5.61 | 3.17 | 2.60 | 4.79 | 3.24 | 4.40 | 4.18 | 1.15 | 4.72 | 4.33 | 4.40 | 4.32 | 3.77 |
Interest | 5.81 | 6.47 | 5.85 | 4.76 | 5.21 | 5.19 | 5.40 | 4.85 | 4.85 | 5.03 | 5.87 | 5.03 | 4.77 |
Depreciation | 3.31 | 3.36 | 3.31 | 3.28 | 3.45 | 3.81 | 3.75 | 3.72 | 3.61 | 3.66 | 3.64 | 3.58 | 3.69 |
Profit before tax | 14.97 | 22.59 | 7.57 | 24.10 | 5.92 | 27.84 | 27.97 | 32.97 | 14.26 | 24.15 | 32.92 | 41.58 | 7.54 |
Tax % | 16.83% | 25.32% | 26.95% | 21.62% | 28.55% | 26.26% | 25.71% | 26.45% | 26.65% | 23.64% | 27.70% | 26.43% | 26.79% |
Net Profit | 12.45 | 16.87 | 5.52 | 18.89 | 4.22 | 20.53 | 20.78 | 24.24 | 10.46 | 18.44 | 23.80 | 30.59 | 5.52 |
EPS in Rs | 1.57 | 2.12 | 0.69 | 2.38 | 0.53 | 2.58 | 2.61 | 3.05 | 1.32 | 2.32 | 2.99 | 3.85 | 0.69 |
Last Updated: August 20, 2025, 4:20 am
Below is a detailed analysis of the quarterly data for Rupa & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 183.90 Cr.. The value appears to be declining and may need further review. It has decreased from 415.48 Cr. (Mar 2025) to 183.90 Cr., marking a decrease of 231.58 Cr..
- For Expenses, as of Jun 2025, the value is 171.67 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 369.61 Cr. (Mar 2025) to 171.67 Cr., marking a decrease of 197.94 Cr..
- For Operating Profit, as of Jun 2025, the value is 12.23 Cr.. The value appears to be declining and may need further review. It has decreased from 45.87 Cr. (Mar 2025) to 12.23 Cr., marking a decrease of 33.64 Cr..
- For OPM %, as of Jun 2025, the value is 6.65%. The value appears to be declining and may need further review. It has decreased from 11.04% (Mar 2025) to 6.65%, marking a decrease of 4.39%.
- For Other Income, as of Jun 2025, the value is 3.77 Cr.. The value appears to be declining and may need further review. It has decreased from 4.32 Cr. (Mar 2025) to 3.77 Cr., marking a decrease of 0.55 Cr..
- For Interest, as of Jun 2025, the value is 4.77 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.03 Cr. (Mar 2025) to 4.77 Cr., marking a decrease of 0.26 Cr..
- For Depreciation, as of Jun 2025, the value is 3.69 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.58 Cr. (Mar 2025) to 3.69 Cr., marking an increase of 0.11 Cr..
- For Profit before tax, as of Jun 2025, the value is 7.54 Cr.. The value appears to be declining and may need further review. It has decreased from 41.58 Cr. (Mar 2025) to 7.54 Cr., marking a decrease of 34.04 Cr..
- For Tax %, as of Jun 2025, the value is 26.79%. The value appears to be increasing, which may not be favorable. It has increased from 26.43% (Mar 2025) to 26.79%, marking an increase of 0.36%.
- For Net Profit, as of Jun 2025, the value is 5.52 Cr.. The value appears to be declining and may need further review. It has decreased from 30.59 Cr. (Mar 2025) to 5.52 Cr., marking a decrease of 25.07 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.69. The value appears to be declining and may need further review. It has decreased from 3.85 (Mar 2025) to 0.69, marking a decrease of 3.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:10 pm
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 904 | 973 | 1,015 | 1,093 | 1,120 | 1,149 | 975 | 1,313 | 1,475 | 1,143 | 1,217 | 1,239 | 1,213 |
Expenses | 774 | 835 | 883 | 954 | 965 | 998 | 861 | 1,055 | 1,207 | 1,054 | 1,099 | 1,108 | 1,088 |
Operating Profit | 130 | 138 | 132 | 139 | 155 | 151 | 114 | 257 | 269 | 89 | 118 | 131 | 125 |
OPM % | 14% | 14% | 13% | 13% | 14% | 13% | 12% | 20% | 18% | 8% | 10% | 11% | 10% |
Other Income | 7 | 5 | 4 | 3 | 2 | 2 | 7 | 7 | 11 | 16 | 13 | 18 | 17 |
Interest | 25 | 24 | 19 | 11 | 8 | 19 | 19 | 13 | 19 | 23 | 21 | 21 | 21 |
Depreciation | 11 | 15 | 15 | 16 | 16 | 15 | 19 | 14 | 14 | 13 | 15 | 14 | 15 |
Profit before tax | 102 | 104 | 102 | 115 | 134 | 119 | 84 | 237 | 247 | 69 | 95 | 113 | 106 |
Tax % | 35% | 35% | 35% | 37% | 36% | 38% | 26% | 26% | 22% | 22% | 26% | 26% | |
Net Profit | 66 | 68 | 66 | 72 | 86 | 74 | 62 | 175 | 192 | 54 | 70 | 83 | 78 |
EPS in Rs | 8.31 | 8.57 | 8.29 | 9.09 | 10.84 | 9.33 | 7.78 | 22.04 | 24.12 | 6.76 | 8.77 | 10.47 | 9.85 |
Dividend Payout % | 30% | 32% | 33% | 30% | 28% | 32% | 39% | 23% | 12% | 44% | 34% | 29% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 3.03% | -2.94% | 9.09% | 19.44% | -13.95% | -16.22% | 182.26% | 9.71% | -71.88% | 29.63% | 18.57% |
Change in YoY Net Profit Growth (%) | 0.00% | -5.97% | 12.03% | 10.35% | -33.40% | -2.26% | 198.47% | -172.54% | -81.59% | 101.50% | -11.06% |
Rupa & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 2% |
5 Years: | 5% |
3 Years: | -6% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | 2% |
5 Years: | 6% |
3 Years: | -24% |
TTM: | 1% |
Stock Price CAGR | |
---|---|
10 Years: | -5% |
5 Years: | 0% |
3 Years: | -17% |
1 Year: | -39% |
Return on Equity | |
---|---|
10 Years: | 14% |
5 Years: | 13% |
3 Years: | 7% |
Last Year: | 8% |
Last Updated: September 5, 2025, 1:10 pm
Balance Sheet
Last Updated: August 11, 2025, 2:41 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
Reserves | 278 | 320 | 359 | 431 | 491 | 537 | 570 | 722 | 874 | 904 | 950 | 1,010 |
Borrowings | 198 | 212 | 148 | 84 | 116 | 210 | 179 | 161 | 370 | 258 | 235 | 238 |
Other Liabilities | 176 | 202 | 166 | 192 | 284 | 261 | 234 | 265 | 325 | 218 | 253 | 256 |
Total Liabilities | 661 | 742 | 681 | 716 | 899 | 1,016 | 991 | 1,156 | 1,577 | 1,388 | 1,446 | 1,512 |
Fixed Assets | 145 | 137 | 156 | 169 | 167 | 182 | 185 | 193 | 210 | 233 | 244 | 241 |
CWIP | 4 | 19 | 9 | -0 | 8 | 3 | 6 | 19 | 27 | 21 | 0 | -0 |
Investments | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | 27 |
Other Assets | 511 | 587 | 517 | 546 | 724 | 832 | 799 | 944 | 1,340 | 1,134 | 1,202 | 1,244 |
Total Assets | 661 | 742 | 681 | 716 | 899 | 1,016 | 991 | 1,156 | 1,577 | 1,388 | 1,446 | 1,512 |
Below is a detailed analysis of the balance sheet data for Rupa & Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,010.00 Cr.. The value appears strong and on an upward trend. It has increased from 950.00 Cr. (Mar 2024) to 1,010.00 Cr., marking an increase of 60.00 Cr..
- For Borrowings, as of Mar 2025, the value is 238.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 235.00 Cr. (Mar 2024) to 238.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 256.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 253.00 Cr. (Mar 2024) to 256.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,512.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,446.00 Cr. (Mar 2024) to 1,512.00 Cr., marking an increase of 66.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 241.00 Cr.. The value appears to be declining and may need further review. It has decreased from 244.00 Cr. (Mar 2024) to 241.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 27.00 Cr., marking an increase of 27.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,244.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,202.00 Cr. (Mar 2024) to 1,244.00 Cr., marking an increase of 42.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,512.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,446.00 Cr. (Mar 2024) to 1,512.00 Cr., marking an increase of 66.00 Cr..
Notably, the Reserves (1,010.00 Cr.) exceed the Borrowings (238.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -68.00 | -74.00 | -16.00 | 55.00 | 39.00 | -59.00 | -65.00 | 96.00 | -101.00 | -169.00 | -117.00 | -107.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 66 | 69 | 62 | 70 | 114 | 126 | 94 | 101 | 135 | 138 | 146 | 151 |
Inventory Days | 249 | 287 | 227 | 230 | 234 | 281 | 426 | 233 | 336 | 293 | 250 | 283 |
Days Payable | 75 | 74 | 65 | 78 | 116 | 110 | 123 | 97 | 127 | 78 | 88 | 93 |
Cash Conversion Cycle | 240 | 282 | 224 | 222 | 232 | 298 | 398 | 237 | 345 | 353 | 308 | 340 |
Working Capital Days | 66 | 74 | 69 | 86 | 104 | 112 | 142 | 113 | 134 | 178 | 154 | 162 |
ROCE % | 27% | 25% | 23% | 24% | 25% | 20% | 14% | 30% | 25% | 8% | 10% | 11% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Motilal Oswal Nifty Microcap 250 Index Fund | 23,765 | 0.11 | 0.64 | 23,765 | 2025-04-22 15:56:53 | 0% |
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Basic EPS (Rs.) | 10.47 | 8.77 | 6.76 | 24.12 | 22.04 |
Diluted EPS (Rs.) | 10.47 | 8.77 | 6.76 | 24.12 | 22.04 |
Cash EPS (Rs.) | 12.28 | 10.61 | 8.41 | 25.84 | 23.74 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 127.78 | 120.31 | 114.50 | 110.74 | 91.62 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 127.78 | 120.31 | 114.50 | 110.74 | 91.62 |
Revenue From Operations / Share (Rs.) | 155.64 | 152.77 | 143.55 | 185.13 | 164.85 |
PBDIT / Share (Rs.) | 18.61 | 16.81 | 13.20 | 35.08 | 33.23 |
PBIT / Share (Rs.) | 16.79 | 14.96 | 11.54 | 33.33 | 31.50 |
PBT / Share (Rs.) | 14.18 | 11.89 | 8.69 | 30.98 | 29.81 |
Net Profit / Share (Rs.) | 10.46 | 8.76 | 6.75 | 24.09 | 22.01 |
NP After MI And SOA / Share (Rs.) | 10.46 | 8.76 | 6.75 | 24.09 | 22.01 |
PBDIT Margin (%) | 11.95 | 11.00 | 9.19 | 18.94 | 20.15 |
PBIT Margin (%) | 10.78 | 9.79 | 8.03 | 18.00 | 19.10 |
PBT Margin (%) | 9.11 | 7.78 | 6.05 | 16.73 | 18.08 |
Net Profit Margin (%) | 6.72 | 5.73 | 4.70 | 13.01 | 13.35 |
NP After MI And SOA Margin (%) | 6.72 | 5.73 | 4.70 | 13.01 | 13.35 |
Return on Networth / Equity (%) | 8.18 | 7.28 | 5.89 | 21.75 | 24.02 |
Return on Capital Employeed (%) | 12.73 | 12.02 | 9.67 | 28.69 | 32.55 |
Return On Assets (%) | 5.51 | 4.82 | 3.87 | 12.16 | 15.02 |
Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Debt / Equity (X) | 0.22 | 0.23 | 0.26 | 0.40 | 0.19 |
Asset Turnover Ratio (%) | 0.83 | 0.85 | 0.77 | 1.04 | 1.17 |
Current Ratio (X) | 2.62 | 2.62 | 2.53 | 2.02 | 2.33 |
Quick Ratio (X) | 1.65 | 1.69 | 1.42 | 1.13 | 1.34 |
Inventory Turnover Ratio (X) | 1.38 | 1.14 | 0.94 | 1.58 | 1.14 |
Dividend Payout Ratio (NP) (%) | 0.00 | 34.19 | 44.40 | 20.72 | 13.61 |
Dividend Payout Ratio (CP) (%) | 0.00 | 28.23 | 35.61 | 19.32 | 12.61 |
Earning Retention Ratio (%) | 0.00 | 65.81 | 55.60 | 79.28 | 86.39 |
Cash Earning Retention Ratio (%) | 0.00 | 71.77 | 64.39 | 80.68 | 87.39 |
Interest Coverage Ratio (X) | 7.13 | 6.48 | 4.64 | 14.92 | 19.70 |
Interest Coverage Ratio (Post Tax) (X) | 5.01 | 4.56 | 3.37 | 11.25 | 14.05 |
Enterprise Value (Cr.) | 1453.77 | 1900.06 | 1755.81 | 3720.98 | 2471.71 |
EV / Net Operating Revenue (X) | 1.17 | 1.56 | 1.54 | 2.52 | 1.88 |
EV / EBITDA (X) | 9.81 | 14.19 | 16.70 | 13.32 | 9.34 |
MarketCap / Net Operating Revenue (X) | 1.15 | 1.56 | 1.42 | 2.37 | 1.87 |
Retention Ratios (%) | 0.00 | 65.80 | 55.59 | 79.27 | 86.38 |
Price / BV (X) | 1.40 | 1.98 | 1.78 | 3.96 | 3.36 |
Price / Net Operating Revenue (X) | 1.15 | 1.56 | 1.42 | 2.37 | 1.87 |
EarningsYield | 0.05 | 0.03 | 0.03 | 0.05 | 0.07 |
After reviewing the key financial ratios for Rupa & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.47. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 10.47, marking an increase of 1.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.47. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 10.47, marking an increase of 1.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.28. This value is within the healthy range. It has increased from 10.61 (Mar 24) to 12.28, marking an increase of 1.67.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 127.78. It has increased from 120.31 (Mar 24) to 127.78, marking an increase of 7.47.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 127.78. It has increased from 120.31 (Mar 24) to 127.78, marking an increase of 7.47.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 155.64. It has increased from 152.77 (Mar 24) to 155.64, marking an increase of 2.87.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.61. This value is within the healthy range. It has increased from 16.81 (Mar 24) to 18.61, marking an increase of 1.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.79. This value is within the healthy range. It has increased from 14.96 (Mar 24) to 16.79, marking an increase of 1.83.
- For PBT / Share (Rs.), as of Mar 25, the value is 14.18. This value is within the healthy range. It has increased from 11.89 (Mar 24) to 14.18, marking an increase of 2.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 10.46. This value is within the healthy range. It has increased from 8.76 (Mar 24) to 10.46, marking an increase of 1.70.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 10.46. This value is within the healthy range. It has increased from 8.76 (Mar 24) to 10.46, marking an increase of 1.70.
- For PBDIT Margin (%), as of Mar 25, the value is 11.95. This value is within the healthy range. It has increased from 11.00 (Mar 24) to 11.95, marking an increase of 0.95.
- For PBIT Margin (%), as of Mar 25, the value is 10.78. This value is within the healthy range. It has increased from 9.79 (Mar 24) to 10.78, marking an increase of 0.99.
- For PBT Margin (%), as of Mar 25, the value is 9.11. This value is below the healthy minimum of 10. It has increased from 7.78 (Mar 24) to 9.11, marking an increase of 1.33.
- For Net Profit Margin (%), as of Mar 25, the value is 6.72. This value is within the healthy range. It has increased from 5.73 (Mar 24) to 6.72, marking an increase of 0.99.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.72. This value is below the healthy minimum of 8. It has increased from 5.73 (Mar 24) to 6.72, marking an increase of 0.99.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.18. This value is below the healthy minimum of 15. It has increased from 7.28 (Mar 24) to 8.18, marking an increase of 0.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.73. This value is within the healthy range. It has increased from 12.02 (Mar 24) to 12.73, marking an increase of 0.71.
- For Return On Assets (%), as of Mar 25, the value is 5.51. This value is within the healthy range. It has increased from 4.82 (Mar 24) to 5.51, marking an increase of 0.69.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.22, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has decreased from 0.85 (Mar 24) to 0.83, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 2.62. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.62.
- For Quick Ratio (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.65, marking a decrease of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 4. It has increased from 1.14 (Mar 24) to 1.38, marking an increase of 0.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 34.19 (Mar 24) to 0.00, marking a decrease of 34.19.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 28.23 (Mar 24) to 0.00, marking a decrease of 28.23.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 65.81 (Mar 24) to 0.00, marking a decrease of 65.81.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 71.77 (Mar 24) to 0.00, marking a decrease of 71.77.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.13. This value is within the healthy range. It has increased from 6.48 (Mar 24) to 7.13, marking an increase of 0.65.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.01. This value is within the healthy range. It has increased from 4.56 (Mar 24) to 5.01, marking an increase of 0.45.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,453.77. It has decreased from 1,900.06 (Mar 24) to 1,453.77, marking a decrease of 446.29.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has decreased from 1.56 (Mar 24) to 1.17, marking a decrease of 0.39.
- For EV / EBITDA (X), as of Mar 25, the value is 9.81. This value is within the healthy range. It has decreased from 14.19 (Mar 24) to 9.81, marking a decrease of 4.38.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.56 (Mar 24) to 1.15, marking a decrease of 0.41.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 65.80 (Mar 24) to 0.00, marking a decrease of 65.80.
- For Price / BV (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.98 (Mar 24) to 1.40, marking a decrease of 0.58.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.56 (Mar 24) to 1.15, marking a decrease of 0.41.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Rupa & Company Ltd:
- Net Profit Margin: 6.72%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.73% (Industry Average ROCE: 5.47%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.18% (Industry Average ROE: 10.73%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.01
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 19.7 (Industry average Stock P/E: 39.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.72%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Textiles - Hosiery/Knitwear | Metro Tower, 8th Floor, Kolkata West Bengal 700071 | connect@rupa.co.in http://www.rupa.co.in |
Management | |
---|---|
Name | Position Held |
Mr. Prahlad Rai Agarwala | Chairman |
Mr. Ghanshyam Prasad Agarwala | Vice Chairman |
Mr. Kunj Bihari Agarwal | Managing Director |
Mr. Ramesh Agarwal | Whole Time Director |
Mr. Mukesh Agarwal | Whole Time Director |
Mr. Vikash Agarwal | Whole Time Director |
Mr. Niraj Kabra | Executive Director |
Mr. Ashok Bhandari | Independent Director |
Mr. Sunil Rewachand Chandiramani | Independent Director |
Mr. Joginder Pal Dua | Independent Director |
Mr. Sumit Malhotra | Independent Director |
Mrs. Mamta Binani | Independent Director |
Mr. Arvind Baheti | Independent Director |
Mr. Vijay Chhibber | Independent Director |
FAQ
What is the intrinsic value of Rupa & Company Ltd?
Rupa & Company Ltd's intrinsic value (as of 05 September 2025) is 171.82 which is 12.78% lower the current market price of 197.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,568 Cr. market cap, FY2025-2026 high/low of 340/174, reserves of ₹1,010 Cr, and liabilities of 1,512 Cr.
What is the Market Cap of Rupa & Company Ltd?
The Market Cap of Rupa & Company Ltd is 1,568 Cr..
What is the current Stock Price of Rupa & Company Ltd as on 05 September 2025?
The current stock price of Rupa & Company Ltd as on 05 September 2025 is 197.
What is the High / Low of Rupa & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Rupa & Company Ltd stocks is 340/174.
What is the Stock P/E of Rupa & Company Ltd?
The Stock P/E of Rupa & Company Ltd is 19.7.
What is the Book Value of Rupa & Company Ltd?
The Book Value of Rupa & Company Ltd is 128.
What is the Dividend Yield of Rupa & Company Ltd?
The Dividend Yield of Rupa & Company Ltd is 1.52 %.
What is the ROCE of Rupa & Company Ltd?
The ROCE of Rupa & Company Ltd is 10.9 %.
What is the ROE of Rupa & Company Ltd?
The ROE of Rupa & Company Ltd is 8.39 %.
What is the Face Value of Rupa & Company Ltd?
The Face Value of Rupa & Company Ltd is 1.00.